Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00802152 · ClinicalTrials.gov registry record · NA

Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy

A NA study of Hypertension and Diabetes, sponsored by University of Missouri-Columbia.

Completed
Registry status
NA
Development phase
108
Enrollment target
1
Study location

NCT00802152: Completed NA study of Hypertension and Diabetes, sponsored by University of Missouri-Columbia.

NCT00802152 is a NA study of Hypertension and Diabetes that has completed, run by University of Missouri-Columbia. The registered enrollment target is 108 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00802152, a NA study of Hypertension and Diabetes, has completed, sponsored by University of Missouri-Columbia.

COMPLETED
Registry status
NA
Development phase
108 participants
Enrollment target
1
Study location

Study Summary

In-home health monitoring devices have the potential to increase the speed and ease of modifying treatment for ambulatory patients living with chronic conditions. This study examines the implementation and effectiveness of remote data transmission from in-home devices (blood glucose meter/blood pressure machine) to the clinic on treatment outcomes in patients with diabetes who have out of range blood glucose (BG) or systolic blood pressure (BP) measurements. We test whether the short-term targeted use of in-home monitoring devices facilitates management for providers and improves outcome measures for patients.

Conditions Studied

Interventions

  • OTHER Home monitoring

Study Locations (1)

Missouri

  • University of Missouri, Dept. of Family and Community Medicine - Columbia

Trial Details

FieldValue
Enrollment Target 108 participants
Start Date 2009-05
Est. Completion 2011-06
Phase NA
University of Missouri-Columbia

291 total trials

What the finished NCT00802152 record still lists

NCT00802152 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Home monitoring is the first listed.

NCT00802152 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT00802152 about?

NCT00802152 is a clinical study titled "Using Health Information Technology (HIT) to Improve Ambulatory Chronic Disease Care: Smart Device Substudy". In-home health monitoring devices have the potential to increase the speed and ease of modifying treatment for ambulatory patients living with chronic conditions. This study examines the implementation and effectiveness of remote data transmission from in-home devices (blood glucose meter/blood pres...

What is the current status of trial NCT00802152?

This trial is currently completed. It is a NA study. The enrollment target is 108 participants. The study started on 2009-05. Estimated completion is 2011-06.

What conditions does trial NCT00802152 study?

This clinical trial studies the following conditions: Hypertension, Diabetes.

What interventions are being tested in trial NCT00802152?

The interventions under investigation include: Home monitoring (OTHER).

Who is sponsoring clinical trial NCT00802152?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00802152 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00802152's enrollment target sits among peer trials

108 285th of 470 higher than 184 of 470 other Hypertension trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02703207 · 108 participants · NA

    Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • NCT02744677 · 108 participants · NA

    COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

  • NCT02781883 · 108 participants · Phase 2

    Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

  • NCT03848663 · 108 participants · NA

    Visual Remapping to Aid Reading With Field Loss

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00802152, the US trial registry maintained by the National Library of Medicine. NCT00802152 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.